[an error occurred while processing this directive]
Skip to Main Content

Latest News

March 29, 2010
Volume 88, Number 13
p. 21
Article appeared online March 24, 2010

'Prochelator' Corrals Copper On Cue

ACS Meeting News: Protease found in brains of those with Alzheimer's triggers release of potentially therapeutic copper chelator

Amanda Yarnell

Cooper Chelator
  • Print this article
  • Email the editor

Latest News

October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

A protease found in the brains of those with Alzheimer's disease can be used to trigger the release of a chelating compound designed to mop up rogue copper, Duke University chemist Katherine J. Franz reported at this week's ACS national meeting in San Francisco.

Binding of copper to amyloid-β, a key protein player in Alzheimer's, is thought to promote both protein aggregation and the formation of damaging reactive oxygen species such as OH•. Hoping to capture and neutralize that copper, Franz and graduate student Drew S. Folk designed a "prochelator" peptide that releases a copper-chelating compound when cleaved by β-secretase, a brain enzyme closely associated with Alzheimer's (J. Am. Chem. Soc., DOI: 10.1021/ja100943r).

That protease trims off the first four amino acids of the prochelator, leaving behind a peptide with an amino terminal copper binding site that can coordinate copper in a square planar Cu(II) complex (shown). The prochelator, when processed by β-secretase in vitro, disassembles and prevents the formation of copper-induced amyloid-β aggregates. It also suppresses the copper-catalyzed formation of reactive oxygen species. Franz's team is now working to tweak the prochelator so that it might make it through the bloodstream and into the brain.

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!